These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8524943)

  • 1. Site-directed mutagenesis of baboon CD14 to the human sequence allows for antibody recognition and enhanced LPS binding.
    DeGraw JS; Gao J; Leturcq DJ; Thornton GB; Moriarty AM
    Prog Clin Biol Res; 1995; 392():365-8. PubMed ID: 8524943
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic strategies to block LPS interactions with its receptor.
    Leturcq DJ; Moriarty AM; Talbott G; Winn RK; Martin TR; Ulevitch RJ
    Prog Clin Biol Res; 1995; 392():473-7. PubMed ID: 8524954
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.
    Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D
    J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C
    Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of CD14 transfected cells to study LPS-antagonist action.
    Delude RL; Savedra R; Yamamoto S; Golenbock DT
    Prog Clin Biol Res; 1995; 392():487-97. PubMed ID: 8524956
    [No Abstract]   [Full Text] [Related]  

  • 6. Escherichia coli and Porphyromonas gingivalis lipopolysaccharide interactions with CD14: implications for myeloid and nonmyeloid cell activation.
    Cunningham MD; Bajorath J; Somerville JE; Darveau RP
    Clin Infect Dis; 1999 Mar; 28(3):497-504. PubMed ID: 10194067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of lipopolysaccharide with macrophages.
    Manthey CL; Vogel SN
    Immunol Ser; 1994; 60():63-81. PubMed ID: 7504530
    [No Abstract]   [Full Text] [Related]  

  • 8. Moesin: a potential LPS receptor on human monocytes.
    Amar S; Oyaisu K; Li L; Van Dyke T
    J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of site-directed mutagenesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation.
    Lamping N; Hoess A; Yu B; Park TC; Kirschning CJ; Pfeil D; Reuter D; Wright SD; Herrmann F; Schumann RR
    J Immunol; 1996 Nov; 157(10):4648-56. PubMed ID: 8906845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual effects of LPS antibodies on cellular uptake of LPS and LPS-induced proinflammatory functions.
    Pollack M; Ohl CA; Golenbock DT; Di Padova F; Wahl LM; Koles NL; Guelde G; Monks BG
    J Immunol; 1997 Oct; 159(7):3519-30. PubMed ID: 9317151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14.
    Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS
    J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane-anchored CD14 is required for LPS-induced TLR4 endocytosis in TLR4/MD-2/CD14 overexpressing CHO cells.
    Shuto T; Kato K; Mori Y; Viriyakosol S; Oba M; Furuta T; Okiyoneda T; Arima H; Suico MA; Kai H
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1402-9. PubMed ID: 16263085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human CD14 mediates recognition and phagocytosis of apoptotic cells.
    Devitt A; Moffatt OD; Raykundalia C; Capra JD; Simmons DL; Gregory CD
    Nature; 1998 Apr; 392(6675):505-9. PubMed ID: 9548256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide (LPS) antibodies regulate cellular uptake of LPS and LPS induced proinflammatory responses.
    Ohl CA; Pollack M
    Prog Clin Biol Res; 1998; 397():227-34. PubMed ID: 9575563
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipopolysaccharide (LPS) labeled with Alexa 488 hydrazide as a novel probe for LPS binding studies.
    Triantafilou K; Triantafilou M; Fernandez N
    Cytometry; 2000 Dec; 41(4):316-20. PubMed ID: 11084617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CD14-independent LPS receptor cluster.
    Triantafilou K; Triantafilou M; Dedrick RL
    Nat Immunol; 2001 Apr; 2(4):338-45. PubMed ID: 11276205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of IFN-gamma in the pathogenesis of LPS lethality.
    Bucklin SE; Russell SW; Morrison DC
    Prog Clin Biol Res; 1994; 388():399-406. PubMed ID: 7831371
    [No Abstract]   [Full Text] [Related]  

  • 18. A CD14 domain with lipopolysaccharide-binding and -neutralizing activity.
    Voss S; Welte S; Fotin-Mleczek M; Fischer R; Ulmer AJ; Jung G; Wiesmüller KH; Brock R
    Chembiochem; 2006 Feb; 7(2):275-86. PubMed ID: 16444757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor.
    Hoess A; Schneider-Mergener J; Liddington RC
    Prog Clin Biol Res; 1995; 392():327-37. PubMed ID: 8524938
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of soluble CD14 fusion proteins and use in an electrochemiluminescent assay for lipopolysaccharide binding.
    Burkhardt M; LopezAcosta A; Reiter K; Lopez V; Lees A
    Protein Expr Purif; 2007 Jan; 51(1):96-101. PubMed ID: 16861002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.